Resistance profile of adefovir dipivoxil (ADV) in immunocompetent and immunocompromised chronic hepatitis B patients after 48 weeks of adefovir dipivoxil therapy
暂无分享,去创建一个
M. Wulfsohn | C. Gibbs | Huiling Yang | W. Delaney | V. Thibault | Y. Benhamou | C. Westland | S. Xiong | C. Brosgart | J. Fry | M. Miller | M. Sullivan